European Patent Office

T 0043/18 of 01.06.2022

European Case Law Identifier
ECLI:EP:BA:2022:T004318.20220601
Date of decision
1 June 2022
Case number
T 0043/18
Petition for review of
-
Application number
10011792.8
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
Abstract on EPC2000 Art 054
Application title
Pharmaceutical dosage form comprising oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
Applicant name
EURO-CELTIQUE S.A.
Opponent name
Acino Pharma AG
James Poole Limited
Setna, Rohan P.
Hoffmann Eitle
Board
3.3.02
Headnote
-
Relevant legal provisions
European Patent Convention Art 54Rules of procedure of the Boards of Appeal Art 11
Keywords
Novelty
Remittal
Catchword
Novelty - purity: decision T 1085/13 followed
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division for

further prosecution.